Entera Bio Ltd — Cash Flow (NASDAQ:ENTX)

Financials

Cash from operating activities 10.42 M9.06 M12.5 M7.31 M6.82 M 7 M Cash from investing activities 86 K17 K102 K17 K3 000 83 K Cash from financing activities 3.92 M25.38 M13 K6.04 M4.48 M 16.75 M Free cash flow 10.42 M9.05 M12.45 M7.29 M6.82 M 6.92 M

新闻

What Pushed Entera Bio (ENTX) To Rally Nearly 16% After Hours - Entera Bio (NASDAQ:ENTX)

H.C. Wainwright重申Opko Health股票买入评级

Opko Health stock rating reiterated at Buy by H.C. Wainwright

Entera Bio任命Geno Germano为董事会主席

Entera Bio appoints Geno Germano as board chairman

OPKO和Entera扩大合作开发口服PTH治疗方案

OPKO and Entera expand collaboration to develop oral PTH treatment

Entera Bio计划于2026年第一季度向FDA提交骨质疏松症药物申请

Entera Bio plans FDA submission for osteoporosis drug in Q1 2026

H.C. Wainwright重申Entera Bio股票买入评级，因FDA认可BMD终点指标

H.C. Wainwright reiterates Buy rating on Entera Bio stock as FDA qualifies BMD endpoint

Entera Bio公司的口服甲状旁腺激素类似物显示持续钙反应